Bayer plans to sell its Crop Science division, BAYER360, amid a decade-low trading period. Investors ponder whether this is an opportunity to buy or to stay away. Additionally, we recap Bayer's 2024 Innovation Update, highlighting key developments and potential implications for the company's future. Stay tuned for insights on Bayer's strategic shift and its implications for the agriculture and pharma sectors.